CoreCap Advisors
AZN icon

CoreCap Advisors’s AstraZeneca AZN Stock Holding History

CoreCap Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$75.1K Sell
465
-54
-10% -$9K ﹤0.01% 1223
2026
Q2 		$98.4K Buy
+519
New +$97.6K ﹤0.01% 1108
2026
Q1 		– Sell
-362
Closed -$66.5K – 2949
2025
Q4 		$66.5K Buy
362
+95
+36% +$16.7K ﹤0.01% 1191
2025
Q3 		$41K Buy
267
+62
+30% +$9.38K ﹤0.01% 1403
2025
Q2 		$28.6K Sell
205
-45
-18% -$6.31K ﹤0.01% 1476
2025
Q1 		$36.7K Sell
250
-71
-22% -$10.3K ﹤0.01% 1300
2024
Q4 		$42.1K Buy
321
+77
+32% +$10.8K ﹤0.01% 1262
2024
Q3 		$37.9K Buy
+244
New +$39.4K ﹤0.01% 1311
2024
Q2 		– Sell
-202
Closed -$27.4K – 1681
2024
Q1 		$27.4K Buy
+202
New +$26.7K ﹤0.01% 1345
2022
Q4 		$52.8K Buy
+389
New +$48.8K ﹤0.01% 969
2022
Q3 		– Sell
-247
Closed -$33K – 657
2022
Q2 		$33K Sell
247
-1,715
-87% -$225K ﹤0.01% 1076
2022
Q1 		$260K Sell
1,962
-55
-3% -$6.6K 0.02% 439
2021
Q4 		$235K Buy
+2,017
New +$237K 0.02% 500

Other funds holding AZN

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank Pictet & Cie (Europe)
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

CoreCap Advisors's AZN Position: Q3 2026 in Review

CoreCap Advisors reduced its AstraZeneca (AZN) stake by 10% in Q3 2026, selling an estimated $9K and leaving 465 shares worth $75.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1223.

CoreCap Advisors first reported a position in AZN in Q4 2021 and has held it in 13 quarters since. The position peaked at $260K in Q1 2022. 365 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • CoreCap Advisors held 465 shares of AstraZeneca worth $75.1K as of Q3 2026.
  • CoreCap Advisors sold 54 AstraZeneca shares in Q3 2026, an estimated $9K.
  • AstraZeneca made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1223 holding.
  • CoreCap Advisors first reported a position in AstraZeneca in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's AstraZeneca position peaked at $260K in Q1 2022.
  • 365 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.